Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT04718883What this trial is testingCD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Mantle Cell LymphomaWho this might be right forMantle Cell Lymphoma Shanghai Ming Ju Biotechnology Co., Ltd. 59
Early research (Phase 1)Active Not RecruitingNCT06192888What this trial is testingGlofitamab and Lenalidomide in People With Mantle Cell LymphomaWho this might be right forMantle Cell LymphomaMCL Memorial Sloan Kettering Cancer Center 39
Early research (Phase 1)Study completedNCT00005580What this trial is testingBryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's LymphomaWho this might be right forLeukemiaLymphoma Virginia Commonwealth University 54
Testing effectiveness (Phase 2)Study completedNCT00438880What this trial is testingAgatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin LymphomaWho this might be right forAdult Non-Hodgkin LymphomaExtranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueNodal Marginal Zone Lymphoma+9 more Mayo Clinic 38
Testing effectiveness (Phase 2)Study completedNCT00096096What this trial is testingTacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00489203What this trial is testingBeclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forHematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+133 more Fred Hutchinson Cancer Center 140
Testing effectiveness (Phase 2)Active Not RecruitingNCT03147885What this trial is testingSelinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin LymphomaWho this might be right forDiffuse Large B-Cell LymphomaRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Extranodal Marginal Zone Lymphoma+12 more Barbara Ann Karmanos Cancer Institute 43
Early research (Phase 1)Study completedNCT00019838What this trial is testingUCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or LeukemiaWho this might be right forLeukemiaLymphoma National Cancer Institute (NCI)
Not applicableNot Yet RecruitingNCT07476378What this trial is testingEvaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell MalignanciesWho this might be right forLymphoma, Large B-Cell, Diffuse (DLBCL)Lymphoma, FollicularLymphoma, Mantle-Cell+3 more Cancer Institute and Hospital, Chinese Academy of Medical Sciences 69
Testing effectiveness (Phase 2)Study completedNCT00724984What this trial is testingStudy of the Safety and Tolerability of PCI-24781 in Patients With LymphomaWho this might be right forLymphomaHodgkin DiseaseLymphoma, Non-Hodgkin Pharmacyclics LLC. 55
Early research (Phase 1)Study completedNCT00003451What this trial is testingInterleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07784101What this trial is testingCompare the Efficacy of ICP-248 in Combination With Orelabrutinib Versus Pirtobrutinib in Participants With Relapsed or Refractory Mantle Cell Lymphoma (r/r MCL).Who this might be right forRelapsed or Refractory Mantle Cell Lymphoma (MCL) Beijing InnoCare Pharma Tech Co., Ltd. 280
Testing effectiveness (Phase 2)Study completedNCT00975975What this trial is testingBasiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood CancerWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+8 more Indiana University 17
Testing effectiveness (Phase 2)Study completedNCT00119730What this trial is testingChemotherapy Followed by Zevalin for Relapsed Mantle Cell LymphomaWho this might be right forMantle Cell Lymphoma Dana-Farber Cancer Institute 30
Testing effectiveness (Phase 2)Study completedNCT00225212What this trial is testingRituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's LymphomaWho this might be right forNon-Hodgkin's LymphomaDiffuse Large Cell LymphomaMantle Cell Lymphoma+3 more Stanford University 35
Testing effectiveness (Phase 2)Ended earlyNCT01116232What this trial is testingSirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell TransplantationWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more Barbara Ann Karmanos Cancer Institute 4
Very early researchUnknownNCT04184414What this trial is testingThe Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological MalignanciesWho this might be right forB Acute Lymphoblastic LeukemiaMantle Cell LymphomaFollicular Lymphoma PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Early research (Phase 1)Study completedNCT00891072What this trial is testingGossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaContiguous Stage II Adult Burkitt Lymphoma+78 more National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT01718691What this trial is testingEfficacy and Safety Study of SyB L-0501 in Combination With Rituximab in Patients With Untreated, Low-grade B Cell Non-Hodgkin's Lymphoma and Mantle Cell LymphomaWho this might be right forLow-grade B Cell Non-Hodgkin's LymphomaMantle Cell Lymphoma Where Hematopoietic Stem Cell Transplantation is Not Indicated SymBio Pharmaceuticals 70